(Q48319289)

10 February 2018

title

Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. (English)

1 reference

10 February 2018

1 reference

6

1 reference

10 February 2018

Akira Arimura

2

object named as

Arimura A

1 reference

10 February 2018

David H. Coy

5

object named as

Coy DH

1 reference

10 February 2018

Fernandez-Durango R

4

object named as

Fernandez-Durango R

1 reference

10 February 2018

author name string

Meyers C

1

1 reference

10 February 2018

Gordin A

3

1 reference

10 February 2018

Drouin J

7

1 reference

10 February 2018

Ferland L

8

1 reference

10 February 2018

Beaulieu M

9

1 reference

10 February 2018

Labrie F

10

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1977

1 reference

10 February 2018

Biochemical and Biophysical Research Communications

published in

1 reference

10 February 2018

volume

74

1 reference

10 February 2018

page(s)

630-636

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

Serum Growth Hormone Patterns in Female Juvenile Diabetics

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Radioimmunoassayable growth hormone in the rat pituitary gland: effects of age, sex and hormonal state

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Inhibition of insulin secretion by somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Diabetic Ketosis: Serial Plasma Growth Hormone Concentrations During Therapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Apparent positive cooperative effects in cyclic AMP and corticosterone production by isolated adrenal cells in response to ACTH analogues.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Studies on the mechanism of somatostatin action on insulin release in man. I. Effect of blockade of alpha-adrenergic receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Partition Chromatography of Oxytocin on ‘Sephadex’

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Studies on the inhibitory effect of somatostatin on glucose induced insulin release in the isolated perfused rat pancreas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Relative effects of somatostatin and two somatostatin analogues on the release of insulin,glucagon and growth hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Structure activity studies on somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Inhibition by Somatostatin of Glucagon and Insulin Release from the Perfused Rat Pancreas in Response to Arginine, Isoproterenol and Theophylline: Evidence for a Preferential Effect on Glucagon Secretion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Growth Hormone and Glucose Interrelationships in Diabetes: Studies with Insulin Infusion During Continuous Blood Glucose Analysis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Glucagon: Role in the Hyperglycemia of Diabetes Mellitus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Inhibitory Action of Somatostatin on Pancreatic α and β Cell Function1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Growth hormone release inhibiting hormone in acromegaly

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Solid phase synthesis of growth hormone-release inhibiting factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

D-Trp8-somatostatin: An analog of somatostatin more potent than the native molecule

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Acid stability of several benzylic protecting groups used in solid-phase peptide synthesis. Rearrangement of O-benzyltyrosine to 3-benzyltyrosine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/0006-291X(77)90349-7

Identifiers

DOI

10.1016/0006-291X(77)90349-7

1 reference

10 February 2018

PubMed ID

836315

1 reference

10 February 2018